ASAM Pocket Guidelines and Patient Guide

Stimulant Use Disorder

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1519511

Contents of this Issue

Navigation

Page 19 of 29

20 Treatment Hyperadrenergic Symptoms of Stimulant Intoxication 63. When patients present with hyperadrenergic symptoms, clinicians should provide ongoing monitoring and management of vital signs— especially heart rate and blood pressure—to prevent complications that may result from untreated sympathomimetic toxicity (CC-S). 64. Clinicians should treat patients in a stimulant-induced hyperadrenergic state with gamma-aminobutyric acid (GABA)- ergic agents (eg, benzodiazepines, phenobarbital, propofol); benzodiazepines can be considered first-line treatment for this purpose (L-S). 65. If the hyperadrenergic state persists despite appropriate improvement in agitation and neuromuscular hyperactivity following treatment with benzodiazepines or other GABAergic agent, clinicians can consider adjunctive treatment with the following medications: a. A beta blocker with concomitant alpha-1 antagonism (eg, carvedilol, labetalol; M-C). b. An alpha-2 adrenergic agonist (eg, dexmedetomidine for severe symptoms, clonidine for mild to moderate symptoms; M-C). c. Where beta blockers are contraindicated, clinicians can consider other pharmacological options such as calcium channel blockers, alpha-1 adrenergic antagonists, alpha-2 adrenergic agonists, and nitric oxide-mediated vasodilators, with consideration of other clinically relevant signs and symptoms (M-C). d. While calcium channel blockers, alpha-1 adrenergic antagonists, alpha-2 adrenergic agonists, and nitric oxide-mediated vasodilators may be most beneficial in treating hypertension and vasospasm, clinicians should be alert to potential side effects, including poor control over tachycardia or reflex tachycardia (M-S). 66. If a patient with stimulant intoxication is experiencing a hypertensive emergency, clinicians should: a. use short-acting agents such as sodium nitroprusside, phentolamine, or dihydropyridine calcium channel blockers (VL-S); b. avoid long-acting antihypertensives to avoid abrupt hemodynamic collapse (VL-S); and c. use nitroglycerin if the patient exhibits signs or symptoms of cardiac ischemia (VL-S). Acute Issues and Complications Chest Pain 67. For patients experiencing chest pain during stimulant intoxication, clinicians should initiate treatment for the underlying intoxication with GABAergic agents (eg, benzodiazepines, phenobarbital, propofol) as long as there are no clinical contraindications (M-C).

Articles in this issue

view archives of ASAM Pocket Guidelines and Patient Guide - Stimulant Use Disorder